Quantum Sensors to Detect Toxic Drug Effects: A New Revolution in Biomedical Science
A joint initiative by the National Institutes of Health and NASA named 'QuSAFE' will enable drug testing without animals by measuring cellular changes at an ultrasensitive level.
When any new drug is discovered, knowing how safe it is for the human body and whether it has any toxic effects is the greatest challenge. Until now, this testing has mostly had to rely on laboratory animals or traditional petri-dish cultures. Now, a very important initiative has been launched by the United States space agency NASA and the health research organization National Institutes of Health (NIH), named the 'QuSAFE' (The Quantum-Enabled Predictive Preclinical NAMs for Toxicity and Safety) Challenge. The purpose of this collaboration is to utilize quantum-enabled sensing methods in biomedical research, so that animal experiments are reduced and human-relevant data can be obtained with greater precision.
This approach focuses particularly on New Approach Methodologies (NAMs), which include in vitro (experiments conducted outside the body in laboratory glassware or a controlled environment) methods such as organoids (three-dimensional miniature organs developed from human cells in the laboratory) and microphysiological systems (microchip-based systems that mimic the biological functions of human organs).
Limitations of Traditional Tests and the Need for Quantum Technology
The preclinical phase is considered the most foundational in drug development. However, the common imaging and conventional assays methods used in laboratories have severe limitations. These methods are often noisy and invasive to cell structures. As a result, extremely weak, early, and low-abundance biological signals arising in cells upon exposure to a drug cannot be detected.
Moreover, many traditional methods are destructive; meaning that cells must be destroyed to make a measurement, making continuous monitoring of dynamic biological changes over time impossible. This is where quantum sensing proves to be decisive. Quantum-enabled sensors provide ultra-high sensitivity, an improved signal-to-noise ratio, and nanoscale resolution (clarity at the billionth-of-a-meter scale). This capability captures biological activities that are impossible to observe with current classical methods.
- Preparing in vitro modelsThree-dimensional organoids or microphysiological systems (MPS) are developed from human cells in the laboratory.
- Quantum sensor integrationSensors based on spin qubits, photonic systems, or squeezed light are coupled with biological samples.
- Ultra-sensitive measurement of drug effectsReal-time measurement of extremely weak and early chemical or electrical signals at the nanoscale without destroying cells.
- Accurate prediction of toxic effectsPrecise data on drug safety is obtained without animal experimentation through the analysis of quantum signals.
How Quantum Sensing Works
Under quantum technology, quantum sensors leverage the fundamental phenomena of quantum mechanics to measure physical parameters. This includes phenomena such as superposition (a state where a particle exists in multiple states simultaneously), quantum entanglement (an unbreakable connection between two or more particles), and quantum squeezing (obtaining precise measurements by reducing uncertainty). In theory, the accuracy of such sensors is limited only by Heisenberg's uncertainty principle, meaning they can be accurate to the ultimate limits of physics.
These sensors are primarily classified into photonic (light-based) or solid-state (solid-matter-based) systems. Photonic sensing utilizes single photons and squeezed light to measure extremely weak signals through interferometric methods. On the other hand, solid-state sensors follow four specific criteria, which necessitate having distinct energy levels and an arrangement that allows them to be coherently controlled.
| Sequence | Criterion | Its role in biological measurement |
|---|---|---|
| 1 | Discrete Energy Levels | The system must have clear and distinguishable energy levels. |
| 2 | State Initialization and Readout | The sensor can be set to a known state and its precise measurement can be read. |
| 3 | Coherent Manipulation | The quantum state of the sensor can be controlled coherently without external disturbance. |
| 4 | Interaction with Physical Quantity | The sensor responds clearly to the specific physical parameter (such as magnetic field or temperature). |
In biomedical applications, spin qubits or nanoparticles provide an extremely sensitive response to the electrical and magnetic activities taking place inside cells. For example, trapped ions couple with electric fields while spin systems measure magnetic fields. By eliminating projection noise, these systems enable techniques like nano-nuclear magnetic resonance (nano-NMR), which can detect the toxicity of drugs at the molecular level within a single cell.
Global Research Investment and Medical Context
The fundamental objective of biomedical research is to understand and find treatments for human diseases. This process is divided into two main parts: clinical (which involves testing on human patients) and pre-clinical (which is conducted in laboratories on animals or models). The reliability of pre-clinical data in drug development is extremely critical because false results invite billions of dollars in losses and wasted time in clinical trials.
In the year 2024, total global spending on research and development (R&D) reached approximately $2.9 trillion (roughly 2.9 trillion dollars). Asia's share in this global investment remained at nearly 45%. In terms of countries, China and America were at almost equal levels; China spent approximately $785.9 billion and America spent $781.8 billion.
અબજ $
According to National Science Foundation statistics on basic research funding in the United States, federal agencies provided only 44% of the $86 billion spent in 2015. In this research, the NIH and pharmaceutical companies allocated $26.4 billion (28%) and $27 billion (29%) respectively, while biotechnology companies provided $17.9 billion (19%) and medical device companies gave $9.2 billion (10%). Between 1995 and 2010, the NIH's medical research budget increased from $11 billion to $27 billion, yet the number of new drugs approved by the FDA remained largely stable during that period.
From Space to Earth: The Convergence of NASA and Medical Science
The NIH-NASA QuSAFE initiative directly supports NASA's Biological and Physical Sciences Division. A common question arises as to why a space agency would be interested in drug testing. During long-term human missions, such as journeys to the Moon and Mars, astronauts are subjected to the extreme pressures of space radiation and microgravity. To understand how drugs and toxic elements affect the human body in space, ultra-sensitive detection methods capable of operating beyond conventional laboratories are required.
The development of quantum sensors can provide portable and highly sensitive diagnostic devices for space missions. At the same time, this very technology will prove revolutionary for the pharmaceutical industry on Earth by reducing reliance on animals and enabling the development of faster and safer drugs. Recent advancements in the field of sensor development will not only enhance the capabilities of space exploration but also provide widespread benefits to human health on Earth.
